* Molecular Templates Inc MTEM.OQ MTEM.O is expected to show
a rise in quarterly revenue when it reports results on May 10
(estimated) .
* The Austin, Texas-based company is expected to report a
748.8% increase in revenue to $35.149 million from $4.14 million
a year ago, according to the mean estimate from 7 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Molecular Templates Inc
is for earnings of 14 cents per share. For the same quarter last
year, the company reported a loss of 48 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 9 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had risen by about 5.4%
in the last three months.
* Wall Street's median 12-month price target for Molecular
Templates Inc is $14, about 38.2% above its last closing price
of $8.65.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Dec. 31 2020 -0.47 -0.42 -0.53 Missed -26.3
Sep. 30 2020 -0.56 -0.55 -0.47 Beat 14.8
Jun. 30 2020 -0.68 -0.48 -0.65 Missed -34.9
Mar. 31 2020 -0.35 -0.32 -0.48 Missed -50.7
Dec. -0.18 -0.25 -0.41 Missed -61.4
31 2019
Sep. 30 2019 -0.21 -0.24 -0.44 Missed -86.4
Jun. 30 2019 -0.24 -0.23 -0.25 Missed -8.7
Mar. 31 2019 -0.21 -0.22 -0.17 Beat 22
This summary was machine generated May 7 at 20:31 GMT. All
figures in US dollars unless otherwise stated